Divalproex in the long-term treatment of chronic daily headache

Headache

Volumn 41, Issue 3, 2001, Pages 271-278

  Freitag, Frederick G ^a,b,c   Diamond, Seymour ^a,b   Diamond, Merle L ^a,b   Urban, George J ^a,b  

^a DIAMOND HEADACHE CLINIC   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c MIDWESTERN UNIVERSITY   (United States)

Author keywords

Chronic daily headaches; Divalproex sodium; Long term treatment; Migraine

Indexed keywords

VALPROATE SEMISODIUM;

ADULT; AGE; ARTICLE; BODY WEIGHT DISORDER; CHRONIC DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENDER; HEADACHE; HUMAN; LIVER TOXICITY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRIORITY JOURNAL; TENSION HEADACHE;

ADULT; BODY WEIGHT; FEMALE; HEADACHE DISORDERS; HUMANS; MALE; MIGRAINE DISORDERS; RETROSPECTIVE STUDIES; TENSION-TYPE HEADACHE; TIME FACTORS; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0035080026     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2001.111006271.x     Document Type: Article

References (5)

1. Mathew NT, Saper JR, Silberstein SD, et al. Migraine prophylaxis with divalproex. Arch Neurol. 1995;52: 281-286.
2. Klapper J. Divalproex sodium in migraine prophylaxis: a dose-controlled study [published correction appears in Cephalalgia. 1997;17:798]. Cephalalgia. 1997;17:103-108.
3. Silberstein SD, Collins SD, for the Long-term Safety of Depakote in Headache Prophylaxis Study Group. Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Headache. 1999;39:633-643.
4. Sorensen KV. Valproate: a new drug in migraine prophylaxis. Acta Neurol Scand. 1988;78:346-348.
5. Hering R, Kuritzky A. Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia. 1989;9:195-198.